Showing results (351-360 of 384) with videos related to

Sort By:
Pageof 39
Circulation|December 18, 2023
Reduced Ejection Fraction in Elite Endurance Athletes: Clinical and Genetic Overlap With Dilated CardiomyopathyGuido Claessen, Ruben De Bosscher, Kristel Janssens, et al.
Circulation|December 18, 2025
Bradycardia in Athletes: Prevalence, Mechanisms, and RisksPaolo D'Ambrosio, Jarne De Paepe, Luke W Spencer, et al.
JAMA Neurology|February 16, 2026
Long-Term Outcomes and Recovery Trajectories in Out-of-Hospital Cardiac Arrest: A 2-Year Follow-Up of the Randomized Clinical TTM2 TrialMalin Hultgren, Erik Blennow Nordström, Susann Ullén, et al.
The Lancet. Infectious Diseases|October 22, 2022
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trialSaye H Khoo, Richard FitzGerald, Geoffrey Saunders, et al.
Critical Care (London, England)|June 17, 2025
Sedation and analgesia in post-cardiac arrest care: a post hoc analysis of the TTM2 trialAmeldina Ceric, Josef Dankiewicz, Tobias Cronberg, et al.
Trials|July 27, 2021
AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letterGareth O Griffiths, Richard FitzGerald, Thomas Jaki, et al.
Lancet (London, England)|May 23, 2016
Late Ebola virus relapse causing meningoencephalitis: a case reportMichael Jacobs, Alison Rodger, David J Bell, et al.
The Journal of Antimicrobial Chemotherapy|August 27, 2021
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled studySaye H Khoo, Richard Fitzgerald, Thomas Fletcher, et al.
BMJ Open|November 15, 2023
REVISE: Re-Evaluating the Inhibition of Stress Erosions in the ICU: a randomised trial protocolAdam M Deane, Waleed Alhazzani, Gordon Guyatt, et al.
Genome Biology|June 7, 2007
Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strainsLaurence Rohmer, Christine Fong, Simone Abmayr, et al.
Pageof 39